Does ELPLAT Cause Interstitial lung disease? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Interstitial lung disease have been filed in association with ELPLAT. This represents 21.1% of all adverse event reports for ELPLAT.
12
Reports of Interstitial lung disease with ELPLAT
21.1%
of all ELPLAT reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From ELPLAT?
Of the 12 reports, 2 (16.7%) resulted in death, 6 (50.0%) required hospitalization, and 2 (16.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELPLAT. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ELPLAT Cause?
Neuropathy peripheral (10)
Neutrophil count decreased (8)
White blood cell count decreased (7)
Hyperammonaemia (6)
Diarrhoea (5)
Nausea (5)
Platelet count decreased (5)
Splenomegaly (5)
Stomatitis (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)